Real-Time Quote
 -0.18 / -0.89%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Versartis, Inc. is an endocrine-focused biopharmaceutical company. It develops long-acting therapeutic proteins for the treatment of endocrine disorders. The company develops new therapeutic proteins utilizing the novel half-life extension technology XTEN. Versartis was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Redwood City, CA.

Contact Information

Versartis, Inc.
275 Shoreline Drive
Redwood City California 94065
P:(650) 963-8580
Investor Relations:
(212) 213-0006



Individual stakeholders51.81%
Other institutional26.85%
Mutual fund holders16.35%

Top Executives

Jeffrey L. ClelandPresident, Chief Executive Officer & Director
Joshua T. BrummChief Financial Officer
Eric HumphrissVice President-Clinical Operations
Paul B. WestbergSenior Vice President-Business Development
Patrick M. MurphyVice President-Manufacturing

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.